Brensocatib
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Pharmacotherapy options and drug development in bronchiectasis: spotlight on dipeptidyl-peptidase inhibitors.
Journal: Expert opinion on pharmacotherapy
Published: April 28, 2026
The effectiveness and value of brensocatib for the treatment of non-cystic fibrosis bronchiectasis.
Journal: Journal of managed care & specialty pharmacy
Published: February 27, 2026
Cystic fibrosis year in review 2025.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: February 16, 2026
Targeting Neutrophil Function as Therapy for Hidradenitis Suppurativa.
Journal: International journal of molecular sciences
Published: February 04, 2026
Anti-inflammatory therapies for bronchiectasis.
Journal: Current opinion in infectious diseases
Published: January 27, 2026
Bronchiectasis in the precision medicine era: pathogenesis and therapeutic advances.
Journal: Journal of thoracic disease
Published: January 21, 2026
The Role of Dipeptidyl Peptidase Inhibitors in Pulmonary Diseases.
Journal: Biomedicines
Published: January 20, 2026
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review.
Journal: British journal of pharmacology
Published: January 16, 2026
Brensocatib-Another Therapeutic "Window of Opportunity" for Patients with Bronchiectasis.
Journal: Journal of clinical medicine
Published: January 04, 2026
Clearing the air: Clarifying data and interpretations from the ASPEN trial of brensocatib in bronchiectasis.
Journal: Med (New York, N.Y.)
Published: December 24, 2025
The convergent pathway of obstructive lung disease: the disease-modifying potential of dipeptidyl peptidase 1 inhibition in COPD, asthma and bronchiectasis overlap.
Journal: Drugs in context
Published: November 27, 2025
Last Updated: 06/30/2026